Where
Desert Regional Medical Center
1150 North Indian Canyon Drive
Sinatra Education Center
Palm Springs, CA 92262
|
|
Audience
This workshop is intended for:
- Clinical laboratory personnel currently working in the microbiology laboratory.
- Supervisors and Laboratory Directors of Clinical Microbiology Laboratories.
- Faculty in Clinical Laboratory Science programs.
Continuing Education
Six continuing education contact hours will be offered at the conclusion of the seminar. Hardy Diagnostics is a licensed accrediting agency (#0125) for continuing education and is registered with the State of California Department of Health Laboratory Field Services. Course number for this program is #0125022716.Questions?
Kaley LitzingerHardy Diagnostics
PH: (805)346-2766 ext. 5653
E: LitzingerK@HardyDiagnostics.com
Paul C. Schreckenberger, PhD
Dr. Schreckenberger is currently a Professor of Pathology at Loyola University Chicago Stritch School of Medicine and the Director of the Clinical Microbiology Laboratory and Associate Director of Molecular Pathology at Loyola University Medical Center. Dr. Schreckenberger is co-author of the Color Atlas and Textbook of Diagnostic Microbiology. He is active in the American Society for Microbiology, serving as Chairperson of Division C (Clinical Microbiology) in 2001-2002. He has written over 250 articles, abstracts, monographs and self-study courses and serves as a member of the editorial board for the Journal of Clinical Microbiology. His research interests are identification and characterization of enteric and non-fermenting gram-negative bacilli, rapid and automated identification of bacteria, methods for detection of antimicrobial resistance and lowering laboratory costs by controlling utilization.
Description
In this six-hour workshop, participants will learn about changes taking place in the practice of clinical microbiology. Topics covered include the role of the gut and urine microbiome in health and disease, laboratory options for rapid identification and susceptibility testing, the use of rapid diagnostic testing to reduce the total cost of care and increase patient satisfaction, and new methods for detection of carbapenemase-producing organisms
Topic 1 - The Gut Microbiome (1.5 hours)
Objectives for Lecture 1:
- Define the terms: microbiota, microbiome, and intestinal dysbiosis
- Explain the role of beneficial bacteria in the gut
- Describe methods for testing and reporting beneficial and dysbiotic bacteria in stool
- Describe methods for testing natural agents for activity against bacteria and yeast
Topic 2 - The Urine Microbiome (1 hour)
Objective for Lecture 2:
- Describe the expanded quantitative urine culture protocol (EQUC)
- Name bacteria present in urine of asymptomatic women and women with overactive bladder that are urine “culture negative”
- Name bacteria present in urine of symptomatic patients with urinary tract infections that may be missed or misidentified using standard urine culture protocols
- Identify changes that may be needed in way we perform urine cultures in the clinical microbiology laboratory
Topic 3 - The Revolution in Infectious Disease Testing and the Importance of MIC Testing (2 hours)
Objective for Lecture 3:
- Discuss the value of the MIC in choosing optimal antibiotic therapy
- Evaluate the effect of delays in effective therapy on patient outcome
- Describe laboratory options for rapid identification of microorganisms
- Describe laboratory options for rapid susceptibility testing of bacteria
- Assess the value of first line use of syndromic test panels
Topic 4- Detecting Carbapenemases – What Every Laboratory Should be Doing (1.5 hours)
Objectives for Lecture 4:
- Describe the five major types of CRE
- Describe difference in CRE, CPE, and CPO
- Review conventional and new approaches to detecting CPOs
- Evaluate your own laboratories readiness for detecting and reporting CPOs
Registration deadline: February 12, 2016.